News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Peter Pisters: Delighted to serve as keynote speaker at Opportunity Austin’s quarterly meeting
Peter Pisters/mdanderson.org
Mar 31, 2025, 02:16

Peter Pisters: Delighted to serve as keynote speaker at Opportunity Austin’s quarterly meeting

Peter Pisters, President at MD Anderson Cancer Center, shared a post on LinkedIn:

“Delighted to serve as Opportunity Austin‘s keynote speaker at today’s quarterly meeting. It was great to represent MD Anderson Cancer Center and speak on our exciting plans for our Austin campus while connecting with leaders and members of the community. Thanks for having me.”

Peter Pisters

More posts featuring Peter Pisters.

cancer MD Anderson Cancer Center OncoDaily Oncology Opportunity Austin Peter Pisters
Special Coverage
Blog
May 1, 2025, 20:49
Jennifer Bires: Patients Carrying Private Fears They Were Too Overwhelmed to Share
Blog
May 1, 2025, 20:14
NCI Center for Global Health Highlights Challenges of Conducting Cancer Trials in LMICs
Blog
May 1, 2025, 19:53
CCI4EU: A European Initiative Supporting Cancer Research and Innovation - ESO
Blog
May 1, 2025, 19:21
Rima Torosyan: Grateful to be part of the Retinoblastoma Workshop at the POEM Group’s 4th Scientific Meeting
Blog
May 1, 2025, 19:08
Jasmine Kamboj: Fantastic conversations on AI in Oncology with trailblazers
Blog
May 1, 2025, 18:56
Hadieh Eslampanah is Participating in the 17th CCI and SIOP Asia Riyadh 2025 Conference as a Board Member
Blog
May 1, 2025, 18:12
Alastair Lamb highlights BJUI session on AI and Medicolegal topics at AUA25
Blog
May 1, 2025, 18:05
Misty Dawn Shields: An amazing night at the "Evening of Promise" gala hosted by American Lung Association
Blog
May 1, 2025, 18:04
Karuna Ganesh reveals E. coli’s role in early-onset colorectal cancer Initiation at AACR25
Drugs
May 1, 2025, 17:54
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Insight
May 1, 2025, 17:49
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey